Globe Life (NYSE:GL) Director Mark Blinn Sells 1,750 Shares

Globe Life Inc. (NYSE:GL) Director Mark Blinn sold 1,750 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the transaction, the director directly owned 3,372 shares of the company’s stock, valued at $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Globe Life Stock Up 0.4%

GL traded up $0.62 during trading hours on Tuesday, hitting $142.04. 425,195 shares of the company’s stock were exchanged, compared to its average volume of 530,763. The stock has a market cap of $11.31 billion, a price-to-earnings ratio of 9.73 and a beta of 0.47. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71. The stock’s 50-day moving average is $139.55 and its two-hundred day moving average is $138.24. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period last year, the firm earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Sell-side analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on GL. JPMorgan Chase & Co. upped their price objective on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Keefe, Bruyette & Woods upped their price target on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 28th. Morgan Stanley reissued an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a research report on Monday, December 15th. TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Finally, Truist Financial raised their target price on shares of Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research note on Friday. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $171.00.

Institutional Trading of Globe Life

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Transcend Capital Advisors LLC raised its holdings in Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after acquiring an additional 84 shares during the period. Natural Investments LLC grew its position in shares of Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after purchasing an additional 87 shares during the last quarter. Intech Investment Management LLC increased its stake in shares of Globe Life by 0.8% during the second quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock worth $1,438,000 after purchasing an additional 95 shares during the period. CX Institutional lifted its holdings in Globe Life by 5.6% during the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock worth $258,000 after purchasing an additional 96 shares during the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC lifted its holdings in Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock worth $646,000 after purchasing an additional 99 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.